Family Medicine · Shreveport, LA
NPI
1467896738
Since 2013
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8383 Millicent Way
Shreveport, LA, 71115
Phone (318) 797-6661
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
2,240 services
Medicare patients, 2024
167
Average age 72
Drug cost, 2024
$108K
1,462 prescriptions
Company payments, 2025
$816
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary M Eskander was code 85025 (blood count), 275 times for 152 patients. In total Mary M Eskander billed 2,240 services in 80 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 275 | 152 | $7.50 | $2,064 |
| 99214 Office E&M - Established | Office | 270 | 142 | $76.97 | $21K |
| 80053 Clinical Chemistry | Office | 246 | 144 | $10.22 | $2,515 |
| 80061 Clinical Chemistry | Office | 191 | 126 | $12.91 | $2,467 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 183 | 122 | $11.13 | $2,037 |
| 83036 Blood Count | Office | 123 | 68 | $9.37 | $1,152 |
| 84443 Clinical Chemistry | Office | 107 | 65 | $16.46 | $1,761 |
| 84439 Clinical Chemistry | Office | 88 | 52 | $8.74 | $769 |
| 99213 Office E&M - Established | Office | 70 | 55 | $59.08 | $4,136 |
| G0008 Administration of influenza virus vaccine | Office | 56 | 55 | $30.16 | $1,689 |
| 90653 Vaccine Product | Office | 53 | 53 | $80.28 | $4,255 |
| 71046 X-ray - Chest | Office | 50 | 42 | $14.26 | $713 |
| 81001 Clinical Chemistry | Office | 45 | 36 | $2.97 | $134 |
| 82306 Clinical Chemistry | Office | 42 | 29 | $28.32 | $1,189 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 42 | 42 | $120.12 | $5,045 |
By year: 2022 $71K for 2,123 services; 2023 $60K for 1,881 services; 2024 $65K for 2,240 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 275 | 152 | $7.50 | $2,064 |
| 80053 Clinical Chemistry | 246 | 144 | $10.22 | $2,515 |
| 80061 Clinical Chemistry | 191 | 126 | $12.91 | $2,467 |
| 83036 Blood Count | 123 | 68 | $9.37 | $1,152 |
| 84443 Clinical Chemistry | 107 | 65 | $16.46 | $1,761 |
| 84439 Clinical Chemistry | 88 | 52 | $8.74 | $769 |
| 81001 Clinical Chemistry | 45 | 36 | $2.97 | $134 |
| 82306 Clinical Chemistry | 42 | 29 | $28.32 | $1,189 |
| 82043 Clinical Chemistry | 39 | 31 | $5.51 | $215 |
| 82570 Clinical Chemistry | 31 | 26 | $4.92 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary M Eskander prescribed most often to Medicare patients was Atorvastatin Calcium, with 158 prescriptions and refills. In total Mary M Eskander wrote 1,462 Medicare prescriptions that cost $108K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 158 | 408 | 48 | $1,589 |
| Levothyroxine Sodium Generic | 82 | 223 | 23 | $555 |
| Lisinopril Generic | 79 | 223 | 24 | $619 |
| Amlodipine Besylate Generic | 51 | 131 | 17 | $395 |
| Simvastatin Generic | 48 | 143 | 14 | $309 |
| Rosuvastatin Calcium Generic | 39 | 93 | 11 | $467 |
| Omeprazole Generic | 38 | 108 | 12 | $216 |
| Hydrochlorothiazide Generic | 37 | 83 | 11 | $145 |
| Losartan Potassium Generic | 37 | 101 | 12 | $491 |
| Metformin Hcl Generic | 29 | 85 | Under 11 | $241 |
| Mounjaro Tirzepatide | 27 | 27 | Under 11 | $27K |
| Metformin Hcl Er Metformin Hcl | 24 | 46 | Under 11 | $94.56 |
| Alendronate Sodium Generic | 23 | 42 | Under 11 | $347 |
| Metoprolol Succinate Generic | 22 | 48 | Under 11 | $348 |
| Pantoprazole Sodium Generic | 21 | 35 | Under 11 | $190 |
Brand drugs: 188 claims; generic drugs: 1,274 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary M Eskander $816 ($816 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novo Nordisk Inc with $135.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 7 | $135 |
| Pfizer Inc. PFE | 7 | $116 |
| Astellas Pharma US Inc 4503.T | 7 | $103 |
| Dexcom, Inc. DXCM | 4 | $77.85 |
| Abbvie Inc. ABBV | 3 | $56.43 |
| Lilly USA, LLC LLY | 3 | $44.98 |
| GlaxoSmithKline, LLC. GSK | 2 | $43.34 |
| Axsome Therapeutics, Inc. AXSM | 2 | $41.06 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.